{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:09:59Z","timestamp":1787065799345,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.resinv.2025.04.005","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T09:13:41Z","timestamp":1744881221000},"page":"488-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Challenges in the diagnosis and treatment of chronic pulmonary aspergillosis in Japan"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0696-5386","authenticated-orcid":false,"given":"Takahiro","family":"Takazono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7609-7679","authenticated-orcid":false,"given":"Masato","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1429-5706","authenticated-orcid":false,"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2025.04.005_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jiac.2013.10.016","article-title":"Pathogenesis and clinical features of chronic pulmonary aspergillosis - is it possible to distinguish CNPA and CCPA clinically?","volume":"20","author":"Izumikawa","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2025.04.005_bib2","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.resinv.2025.04.005_bib3","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3389\/fmicb.2018.01810","article-title":"Recent Advances in diagnosing chronic pulmonary aspergillosis","volume":"9","author":"Takazono","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.resinv.2025.04.005_bib4","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1007\/s00330-018-5434-y","article-title":"The scab-like sign: a CT finding indicative of haemoptysis in patients with chronic pulmonary aspergillosis?","volume":"28","author":"Sato","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.resinv.2025.04.005_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1055\/s-0043-1776998","article-title":"Radiological diagnosis of pulmonary aspergillosis","volume":"45","author":"Laurent","year":"2024","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.04.005_bib6","first-page":"255","article-title":"An update on the role of (18)F-FDG-PET\/CT in major infectious and inflammatory diseases","volume":"9","author":"Kung","year":"2019","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1016\/j.resinv.2025.04.005_bib7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/thx.2010.155515","article-title":"Pulmonary aspergillosis: an alternative diagnosis to lung cancer after positive [18F]FDG positron emission tomography","volume":"66","author":"Baxter","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2025.04.005_bib8","article-title":"Role of serial fluorodeoxyglucose positron emission tomography-computed tomography (18FDG-PET-CT) in assessing treatment response in treatment naive chronic pulmonary aspergillosis subjects","author":"Sehgal","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.resinv.2025.04.005_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00005792-198203000-00005","article-title":"Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity","volume":"61","author":"Binder","year":"1982","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.resinv.2025.04.005_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.04.005_bib11","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1128\/JCM.01475-15","article-title":"Evaluation of a quantitative serological assay for diagnosing chronic pulmonary aspergillosis","volume":"54","author":"Fujiuchi","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2025.04.005_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jinf.2015.11.003","article-title":"Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA)","volume":"72","author":"Page","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2025.04.005_bib13","article-title":"Efficacy of LD bio Aspergillus ICT lateral flow assay for serodiagnosis of chronic pulmonary aspergillosis","volume":"8","author":"Ray","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.resinv.2025.04.005_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03435-22","article-title":"Validity of Platelia Aspergillus IgG and Aspergillus precipitin test to distinguish pulmonary aspergillosis from colonization","volume":"11","author":"Shinfuku","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.resinv.2025.04.005_bib15","first-page":"581","article-title":"Diagnostic significance of Aspergillus species isolated from respiratory samples in an adult pneumology ward","volume":"49","author":"Tashiro","year":"2011","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2025.04.005_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00095-19","article-title":"Evaluation of aspergillus-specific lateral-flow device test using serum and bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis","volume":"57","author":"Takazono","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2025.04.005_bib17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/myc.13444","article-title":"Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda","volume":"65","author":"Namusobya","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.resinv.2025.04.005_bib18","first-page":"1","article-title":"Clinical applications of immunoglobulin G against different individual Aspergillus species for the diagnosis of chronic pulmonary aspergillosis among at-risk populations","author":"Keng","year":"2024","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.resinv.2025.04.005_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3109\/13693786.2012.682228","article-title":"Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis","volume":"50","author":"Izumikawa","year":"2012","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2025.04.005_bib20","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/JCM.02497-16","article-title":"Usefulness of two Aspergillus PCR assays and Aspergillus galactomannan and beta-d-Glucan testing of bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis","volume":"55","author":"Urabe","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2025.04.005_bib21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1440-1843.2009.01548.x","article-title":"Comparison of Aspergillus galactomannan antigen testing with a new cut-off index and Aspergillus precipitating antibody testing for the diagnosis of chronic pulmonary aspergillosis","volume":"14","author":"Kitasato","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2025.04.005_bib22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jinf.2010.08.005","article-title":"Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan","volume":"61","author":"Kohno","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2025.04.005_bib23","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/cid\/ciad420","article-title":"Superior accuracy of Aspergillus plasma cell-free DNA polymerase chain reaction over serum galactomannan for the diagnosis of invasive aspergillosis","volume":"77","author":"Mah","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2025.04.005_bib24","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/JCM.03189-12","article-title":"Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis","volume":"51","author":"White","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2025.04.005_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","article-title":"Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial","volume":"397","author":"Maertens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2025.04.005_bib26","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/657306","article-title":"Efficacy and safety of posaconazole for chronic pulmonary aspergillosis","volume":"51","author":"Felton","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2025.04.005_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijantimicag.2018.06.001","article-title":"Assessment of posaconazole salvage therapy in chronic pulmonary aspergillosis using predefined response criteria","volume":"52","author":"Rodriguez-Goncer","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.resinv.2025.04.005_bib28","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2015.0460","article-title":"Clinical implications of globally emerging azole resistance in Aspergillus fumigatus","volume":"371","author":"Meis","year":"2016","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.resinv.2025.04.005_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/s12879-021-06279-1","article-title":"Clinical and experimental phenotype of azole-resistant Aspergillus fumigatus with a HapE splice site mutation: a case report","volume":"21","author":"Ito","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.resinv.2025.04.005_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3201\/eid2501.171925","article-title":"Trends in azole resistance in Aspergillus fumigatus, The Netherlands, 1994-2016","volume":"25","author":"Buil","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2025.04.005_bib31","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciy859","article-title":"Voriconazole resistance and mortality in invasive aspergillosis: a multicenter retrospective cohort study","volume":"68","author":"Lestrade","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2025.04.005_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21\u201322","author":"Verweij","year":"2015","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.resinv.2025.04.005_bib33","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01062-2016","article-title":"Predictors of mortality in chronic pulmonary aspergillosis","volume":"49","author":"Lowes","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.04.005_bib34","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jiac.2014.01.003","article-title":"Antifungal susceptibility of Aspergillus fumigatus clinical isolates collected from various areas in Japan","volume":"20","author":"Kikuchi","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2025.04.005_bib35","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jiac.2020.11.027","article-title":"Transition of triazole-resistant Aspergillus fumigatus isolates in a Japanese tertiary hospital and subsequent genetic analysis","volume":"27","author":"Takazono","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2025.04.005_bib36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/mmy\/myaa052","article-title":"High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance","volume":"59","author":"Takeda","year":"2021","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2025.04.005_bib37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jiac.2019.09.002","article-title":"Prospective survey of Aspergillus species isolated from clinical specimens and their antifungal susceptibility: a five-year single-center study in Japan","volume":"26","author":"Toyotome","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2025.04.005_bib38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jiac.2016.01.015","article-title":"Multi-azole resistant Aspergillus fumigatus harboring Cyp51A TR46\/Y121F\/T289A isolated in Japan","volume":"22","author":"Hagiwara","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2025.04.005_bib39","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/mmy\/myz003","article-title":"Prospective multicenter surveillance of clinically isolated Aspergillus species revealed azole-resistant Aspergillus fumigatus isolates with TR34\/L98H mutation in the Kyoto and Shiga regions of Japan","volume":"57","author":"Tsuchido","year":"2019","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2025.04.005_bib40","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fmicb.2016.00683","article-title":"Aspergillus fumigatus-related species in clinical practice","volume":"7","author":"Lamoth","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.resinv.2025.04.005_bib41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/myc.13397","article-title":"The accuracy and clinical impact of the morphological identification of Aspergillus species in the age of cryptic species: a single-centre study","volume":"65","author":"Takeda","year":"2022","journal-title":"Mycoses"},{"key":"10.1016\/j.resinv.2025.04.005_bib42","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/13693786.2011.639036","article-title":"A case of bronchial aspergillosis caused by Aspergillus udagawae and its mycological features","volume":"50","author":"Gyotoku","year":"2012","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2025.04.005_bib43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jiac.2018.10.016","article-title":"Successful treatment of invasive pulmonary aspergillosis caused by Aspergillus felis, a cryptic species within the Aspergillus section Fumigati: a case report","volume":"25","author":"Yamairi","year":"2019","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2025.04.005_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02023-18","article-title":"Epidemiology and antifungal susceptibility profile of Aspergillus species: comparison between environmental and clinical isolates from patients with hematologic malignancies","volume":"57","author":"Cho","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2025.04.005_bib45","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S1473-3099(22)00057-3","article-title":"Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India","volume":"22","author":"Sehgal","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.resinv.2025.04.005_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193732","article-title":"Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis","volume":"13","author":"Bongomin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2025.04.005_bib47","article-title":"Antifungal treatment for Japanese patients with chronic pulmonary aspergillosis","author":"Takazono","year":"2024","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.resinv.2025.04.005_bib48","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s40265-019-01127-8","article-title":"Adverse effects associated with long-term administration of azole antifungal agents","volume":"79","author":"Benitez","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.resinv.2025.04.005_bib49","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1093\/cid\/cit600","article-title":"A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French nationwide study","volume":"57","author":"Epaulard","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2025.04.005_bib50","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jamadermatol.2020.1141","article-title":"Voriconazole and the risk of keratinocyte carcinomas among lung transplant recipients in the United States","volume":"156","author":"D'Arcy","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.resinv.2025.04.005_bib51","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/mmy\/myv093","article-title":"The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients confected with nontuberculous mycobacteria","volume":"54","author":"Takeda","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.resinv.2025.04.005_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9020270","article-title":"New\/Different look at the presence of Aspergillus in mycobacterial pulmonary diseases. Long-term retrospective cohort study","volume":"9","author":"Fukushima","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.resinv.2025.04.005_bib53","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00117-2019","article-title":"Nontuberculous mycobacterial pulmonary disease and Aspergillus co-infection: Bonnie and Clyde?","volume":"54","author":"Geurts","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.04.005_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188716","article-title":"Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease","volume":"12","author":"Jhun","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2025.04.005_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/myc.70022","article-title":"Risk factors and prognostic effects of aspergillosis as a complication of nontuberculous mycobacterial pulmonary disease: a nested case-control study","volume":"68","author":"Takazono","year":"2025","journal-title":"Mycoses"},{"key":"10.1016\/j.resinv.2025.04.005_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1468383","article-title":"Drug-drug interactions in the management of non-tuberculous mycobacterial infections","volume":"15","author":"Takeda","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.resinv.2025.04.005_bib57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00228-008-0574-7","article-title":"The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers","volume":"65","author":"Wang","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.resinv.2025.04.005_bib58","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/myc.13129","article-title":"Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: a multicenter study conducted in Japan","volume":"63","author":"Hamada","year":"2020","journal-title":"Mycoses"},{"key":"10.1016\/j.resinv.2025.04.005_bib59","article-title":"Favorable effects of voriconazole trough concentrations exceeding 1 mug\/mL on treatment success and all-cause mortality: a systematic review and meta-analysis","volume":"7","author":"Hanai","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.resinv.2025.04.005_bib60","article-title":"Therapeutic drug monitoring of isavuconazole: serum concentration variability and success rates for reaching target in comparison with voriconazole","volume":"10","author":"Risum","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.resinv.2025.04.005_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00585-18","article-title":"Isavuconazole concentration in real-world practice: consistency with results from clinical trials","volume":"62","author":"Andes","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2025.04.005_bib62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jiac.2022.10.010","article-title":"Efficacy and safety of isavuconazole against deep-seated mycoses: a phase 3, randomized, open-label study in Japan","volume":"29","author":"Kohno","year":"2023","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2025.04.005_bib63","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/cid\/ciaa652","article-title":"Isavuconazole is as effective as and better tolerated than voriconazole for antifungal prophylaxis in lung transplant recipients","volume":"73","author":"Samanta","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.resinv.2025.04.005_bib64","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.resinv.2025.04.005_bib65","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.resinv.2025.04.005_bib66","article-title":"New treatment options for critically important WHO fungal priority pathogens","author":"Kriegl","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.resinv.2025.04.005_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03614-23","article-title":"Human Vgamma9Vdelta2 T cells exhibit antifungal activity against Aspergillus fumigatus and other filamentous fungi","volume":"12","author":"Koga","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.resinv.2025.04.005_bib68","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/jac\/dkac378","article-title":"EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis","volume":"78","author":"Sprute","year":"2022","journal-title":"J Antimicrob Chemother"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525000474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525000474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T19:49:57Z","timestamp":1749584997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534525000474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2212534525000474"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2025.04.005","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in the diagnosis and treatment of chronic pulmonary aspergillosis in Japan","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2025.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of The Japanese Respiratory Society.","name":"copyright","label":"Copyright"}]}}